Literature DB >> 14764462

Secondary prevention for stroke and transient ischaemic attacks.

Keith W Muir.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764462      PMCID: PMC338083          DOI: 10.1136/bmj.328.7435.297

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group.

Authors:  A Rodgers; S MacMahon; G Gamble; J Slattery; P Sandercock; C Warlow
Journal:  BMJ       Date:  1996-07-20

3.  Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease.

Authors:  M R Walters; A Bolster; A G Dyker; K R Lees
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

4.  Use of ramipril in preventing stroke: double blind randomised trial.

Authors:  Jackie Bosch; Salim Yusuf; Janice Pogue; Peter Sleight; Eva Lonn; Badrudin Rangoonwala; Richard Davies; Jan Ostergren; Jeff Probstfield
Journal:  BMJ       Date:  2002-03-23

5.  Short-term prognosis after emergency department diagnosis of TIA.

Authors:  S C Johnston; D R Gress; W S Browner; S Sidney
Journal:  JAMA       Date:  2000-12-13       Impact factor: 56.272

6.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

7.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors: 
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

8.  Post-stroke antihypertensive treatment study. A preliminary result.

Authors: 
Journal:  Chin Med J (Engl)       Date:  1995-09       Impact factor: 2.628

9.  Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services.

Authors:  A J Coull; J K Lovett; P M Rothwell
Journal:  BMJ       Date:  2004-01-26

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

  10 in total
  3 in total

1.  Secondary prevention for stroke and transient ischaemic attacks: Horizons needs expanding.

Authors:  Sumantra Ray; Alexander S F Doney; Ronald S MacWalter
Journal:  BMJ       Date:  2004-04-10

2.  Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugs.

Authors:  Martin Duerden
Journal:  BMJ       Date:  2004-04-10

3.  The PROGRESS trial three years later: time for more action, less distraction.

Authors:  Stephen Macmahon; Bruce Neal; Anthony Rodgers; John Chalmers
Journal:  BMJ       Date:  2004-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.